Global Clinical Diagnostics Outlook 2024-2029: Market Driven by Digital Services and Automation, Molecular Diagnostics and POCT Sectors Rebound after COVID-19
Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Diagnostics Outlook, 2024" report has been added to ResearchAndMarkets.com's offering.
This study examines clinical diagnostics industry trends and growth projections from 2024 to 2029 across five global regions.
It analyzes innovative in vitro diagnostics technologies and applications, major vendors to watch, and growth opportunities in the post-pandemic reality. The research also provides the top 5 predictions for 2024 related to the industry's decentralization trend, the recovery of molecular diagnostics, and the higher investments in automated solutions and novel digital models.
With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare and precision medicine, as the clinical diagnostics industry continues its transition from a centralized to a decentralized testing model. Globally, 2024 is set to be a profitable year for the industry, which will likely witness sustained growth through to 2029. The main growth drivers will be the point-of-care testing (POCT) and molecular diagnostics sectors, which the publisher expects to rebound even more strongly in 2024.
Growth Opportunity Universe
Shift toward Digital Diagnostics Services
Expansion of Clinical Chemistry and Immunoassays to Emerging Markets
Predictive Testing in Molecular Diagnostics for Genetics and Cardiovascular Diseases
Molecular POCT in Clinical Settings
Multiplex POCT for Immunoassay, STI, and AMR Applications
Key Topics Covered:
Analysis Highlights
Analysis Highlights
The 2023 Clinical Diagnostics Industry: Forecast vs. Actual
Top Clinical Diagnostics Predictions for 2024
Strategic Imperatives
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8T
The Impact of the Top 3 Strategic Imperatives on the Clinical Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine
Growth Environment
Segmentation
Growth Environment
Macroeconomic Factors
Top 10 Trends for 2024
Top 10 Growth Opportunities
Global GDP Growth - Mild Global Growth Slowdown from 3.0% in 2023 to 2.6% in 2024 as Key Economies Lose Growth Momentum
Inflation and Interest Rates - Headline Inflation to Continue to Decline; H2 2024 Shift Toward Rate Cuts for Advanced Economies
Currency Trajectory - Dollar to Remain Strong in H1 2024; Emerging Market Currencies to Get Boost from Q3 2024 Onwards
Labor Market - Moderate Unemployment Uptick; Positive Expectations Over Market Sentiment to Support Labor Hoarding
Oil Markets - Q1 OPEC+ Oil Production Cuts; Non-OPEC Production to Rise
Critical Minerals Supplies - Need for Economic Resiliency to Bolster Cross-border and Cross-industry Partnerships
North America - Economic Slowdown Amidst Discretionary Spending Pullback and Elevated Interest Rates
Western Europe - Moderate Growth Pick-up as Inflation Headwinds Ease Gradually; Rebuilding Fiscal Buffers to Take Precedence
Middle East - Non-oil Growth Driven by Economic Diversification to Limit Pullback Caused by a Slowdown in Global Oil Markets
Asia - Emerging Economies to Drive Growth Momentum; Fiscal Measures to Support Chinese Economic Recovery
Revenue Trends - 2024
Forecast Assumptions: Clinical Diagnostics Industry
Clinical Diagnostics Industry by Segment
Revenue Forecast by Subsegment
Revenue Forecast by Segment: Centralized Testing
Revenue Forecast by Segment: Referral & Peripheral and Decentralized Testing
Revenue Forecast by Region
Percent Revenue Forecast by Region
Revenue Forecast Analysis by Region
Competitive Environment
Revenue Share
Revenue Share Analysis
Competitor Matrix
Mergers and Acquisitions
Notable M&As in 2023
M&As: Historical Analytics
Top 5 Predictions - 2024
Prediction 1: Long-term Change in Consumer Behavior Supports Expansion into Self-collection Testing
Prediction 2: Staff Shortages Continue to Drive Double-digit Lab Automation Growth Rate
Prediction 3: Adoption of NGS and Specialized Bioinformatics Tools Will Support Pharma Innovation
Prediction 4: ctDNA Analysis Will Expand the Application of MRD Testing for Precision Oncology
Prediction 5: Partnerships with AI-focused Start-ups to Promote Adoption of AI-based Digital Pathology in Clinical Segments
Industry Snapshot - 2024
2024 Industry Snapshot
Clinical Chemistry and Immunoassays - 2024
Clinical Chemistry and Immunoassays Industry Snapshot
Clinical Chemistry and Immunoassays Industry: Companies to Watch
Molecular Diagnostics - 2024
Molecular Diagnostics Industry Snapshot
Molecular Diagnostics Industry: Companies to Watch
POCT - 2024
POCT Industry Snapshot
POCT Industry: Companies to Watch
Tissue Diagnostics - 2024
Tissue Diagnostics Industry Snapshot
Tissue Diagnostics Industry: Companies to Watch
Conclusions and Future Outlook
For more information about this report visit https://www.researchandmarkets.com/r/w396ne
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900